Long Term: Insulet’s Repeat Revenue Still Needs Reliable Products and Cash
First published
Tubeless insulin pump systems may earn repeat revenue as more people adopt compatible sensors and
software, but 2026 safety recalls create a serious reason to wait for manufacturing evidence.
Long Term: Brookfield Renewable’s Power Growth Needs a Per-Unit Cash Test
First published
More electricity and battery storage could benefit Brookfield Renewable through long-term power contracts, but
acquisitions, debt and accounting losses demand careful unit-level cash checks.
Long Term: Republic Services’ Waste Streams Still Need Attributable Cash
First published
A waste collector may add value by turning its landfills into renewable-gas and recycling assets, but contract
pricing must outweigh falling waste volumes and weak material prices.
Long Term: Comfort Systems’ Backlog Still Needs Profitable Delivery
First published
AI infrastructure may turn electrical and cooling installers into scarce capacity providers, but the return to
shareholders depends on delivering contracted work without labor and margin damage.
Long Term: Amphenol’s Orders Still Need to Become Lasting Cash
First published
AI systems need growing numbers of high-speed data links, and Amphenol may earn from both connectors and
the fiber networks behind them, if demand converts into lasting cash flow.
Delivery orders and a counter-UAS award do not establish earned cash or sustained margins. US$117.52 is the frozen Friday reference; no shares were bought.
Completed Corpus Christi capacity has shipped cargoes, but proposed expansions and high gas spreads do not guarantee lasting cash returns. US$308.75 is a frozen Friday reference, not a purchase.
Water-quality recurring revenue is a conditional thesis, not an automatic benefit from PFAS regulation. US$118.25 is the frozen Friday close; acquisitions and a premium multiple require demonstrated cash returns.
Long Term: Woodward’s Sales Grew. Cash Still Has to Catch Up.
First published
Woodward's aviation service and power-generation sales grew, but higher capital spending reduced quarterly free cash flow. Research watch, not a purchase: US$329.86 is the frozen 13 November 2026 closing reference, not a transaction or fair-value estimate.
Long Term: Albemarle: lithium realised price rebounds without higher tonnes
First published
Research watch, not a purchase recommendation. Original entry: UNAVAILABLE at 15 November 2026, 14:53 SGT. Separate historical reference: US$93.53 per ALB share at 13 November 2026, 16:00 EST, verified later. Neither is an executed trade. Higher realised lithium prices supported Q3 earnings, but repeat cash and attractive equity valuation remain unproven.